Pulmonology Advisor

Long-Term Nintedanib May Stabilize Disease Progression in SARD-ILD-PPF

Patients with SARD-ILD-PPF who continued nintedanib for 12 months or longer had better outcomes than those who discontinued therapy.
ascopubs.org

Comparison of incidence and pattern of interstitial lung disease (ILD) during erlotinib and gefitinib treatment in Japanese pts with NSCLC

Phase I trial of vorinostat in combination with erlotinib in advanced non-small cell lung cancer (NSCLC) patients with EGFR mutations after erlotinib progression ...
The American Journal of Managed Care

The Spectrum of Progressive Fibrosing Interstitial Lung Disease: Clinical and Managed Care Considerations

Progressive fibrosing interstitial lung diseases (ILDs) encompass a wide range of diseases, including hypersensitivity pneumonitis, occupational diseases, granulomatous diseases, drug-induced diseases ...
Healio

Rheumatoid arthritis-ILD associated with excess mortality

Please provide your email address to receive an email when new articles are posted on . Rheumatoid arthritis-related interstitial lung disease was associated with significantly higher rates of excess ...
ascopubs.org

Trastuzumab Deruxtecan‒Related Interstitial Lung Disease/Pneumonitis: Computed Tomography Imaging Patterns to Guide Diagnosis and Management

Ninety patients with advanced cancers who developed T-DXd‒related pneumonitis in two completed single-arm clinical trials were included. Three radiologists independently characterized the CT patterns ...
The American Journal of Managed Care

Genetic Study Establishes Causal Link Between RA and Interstitial Lung Disease Risk

Genetic predisposition to rheumatoid arthritis increases the risk of interstitial lung disease by 15.5%, as shown by Mendelian randomization analysis. The study used 52 single nucleotide polymorphisms ...